• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir.

作者信息

Koenig Tobias, Kempf Tibor, Schultheiss Heinz-Peter, Cornberg Markus, Bauersachs Johann, Schäfer Andreas

机构信息

Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Institute for Cardiac Diagnostics and Therapy, IKDT GmbH, Berlin, Germany.

出版信息

Clin Res Cardiol. 2022 Feb;111(2):233-236. doi: 10.1007/s00392-021-01955-3. Epub 2021 Oct 20.

DOI:10.1007/s00392-021-01955-3
PMID:34669016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8816788/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c7/8816788/d70d4a43bbf4/392_2021_1955_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c7/8816788/9c3444793eae/392_2021_1955_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c7/8816788/d70d4a43bbf4/392_2021_1955_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c7/8816788/9c3444793eae/392_2021_1955_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c7/8816788/d70d4a43bbf4/392_2021_1955_Fig2_HTML.jpg

相似文献

1
Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir.化疗后暴发性细小病毒B19心肌炎：使用替诺福韦进行抗病毒治疗后完全康复。
Clin Res Cardiol. 2022 Feb;111(2):233-236. doi: 10.1007/s00392-021-01955-3. Epub 2021 Oct 20.
2
Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy.采用免疫抑制和抗病毒疗法成功治疗细小病毒B19相关性暴发性心肌炎。
Antivir Ther. 2010;15(4):681-5. doi: 10.3851/IMP1563.
3
Complete recovery of a patient with cardiogenic shock due to parvovirus B19 fulminant myocarditis after treatment with extracorporeal membrane oxygenation and intravenous immunoglobulin.一名因细小病毒B19暴发性心肌炎导致心源性休克的患者在接受体外膜肺氧合和静脉注射免疫球蛋白治疗后完全康复。
Pol Arch Med Wewn. 2015;125(3):199-201. doi: 10.20452/pamw.2717. Epub 2015 Feb 10.
4
Fulminant myocarditis associated with parvovirus B19 infection in a child.一名儿童中与B19细小病毒感染相关的暴发性心肌炎
J Clin Virol. 2008 May;42(1):70-1. doi: 10.1016/j.jcv.2007.12.018. Epub 2008 Feb 29.
5
Parvovirus B19.细小病毒B19
N Engl J Med. 2004 May 6;350(19):2006-7; author reply 2006-7. doi: 10.1056/NEJM200405063501920.
6
Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.一名婴儿感染细小病毒B19后出现的活动性、暴发性、致死性心肌炎。
Clin Infect Dis. 2002 Nov 1;35(9):1027-31. doi: 10.1086/342574. Epub 2002 Oct 11.
7
Human parvovirus B19-associated myocarditis.人细小病毒B19相关性心肌炎
N Engl J Med. 2010 Apr 1;362(13):1248-9. doi: 10.1056/NEJMc0911362.
8
Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports.危及生命的细小病毒B19相关性心肌炎及心脏移植作为可能的治疗方法：两例病例报告
Clin Infect Dis. 1998 Feb;26(2):355-8. doi: 10.1086/516295.
9
A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation.一例胎儿细小病毒B19心肌炎、终末期心力衰竭及围产期心脏移植病例。
Fetal Diagn Ther. 2001 Nov-Dec;16(6):427-32. doi: 10.1159/000053953.
10
The current status of immune modulating therapy for myocarditis: a case of acute parvovirus myocarditis treated with intravenous immunoglobulin.
Am J Med Sci. 2003 Dec;326(6):369-74. doi: 10.1097/00000441-200312000-00013.

引用本文的文献

1
Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches.推进心肌炎的精准医学：基于心内膜心肌活检的诊断和治疗方法的现状与未来展望
J Clin Med. 2023 Jul 31;12(15):5050. doi: 10.3390/jcm12155050.
2
[Polypill strategy for secondary cardiovascular prevention].[心血管疾病二级预防的复方制剂策略]
Inn Med (Heidelb). 2023 May;64(5):510-512. doi: 10.1007/s00108-023-01507-z. Epub 2023 Apr 21.
3
Towards the Antiviral Agents and Nanotechnology-Enabled Approaches Against Parvovirus B19.

本文引用的文献

1
Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients.核苷类似物逆转录酶抑制剂可改善转录活跃的人细小病毒B19阳性患者的临床结局。
J Clin Med. 2021 Apr 29;10(9):1928. doi: 10.3390/jcm10091928.
2
Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure.检测细小病毒 mRNA 作为基于心肌活检的不明原因心力衰竭患者病毒活性的标志物。
Sci Rep. 2020 Dec 18;10(1):22354. doi: 10.1038/s41598-020-78597-4.
3
Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.
针对细小病毒 B19 的抗病毒药物和纳米技术增强型方法。
Front Cell Infect Microbiol. 2022 Jun 20;12:916012. doi: 10.3389/fcimb.2022.916012. eCollection 2022.
检测心肌活检中的病毒 SARS-CoV-2 基因组和组织病理学变化。
ESC Heart Fail. 2020 Oct;7(5):2440-2447. doi: 10.1002/ehf2.12805. Epub 2020 Jun 12.
4
Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock - A European experienced users working group opinion.经欧洲有经验使用者工作组的意见，探讨在急性心力衰竭和心源性休克中使用经瓣膜微型轴流泵的临床情况。
Int J Cardiol. 2019 Sep 15;291:96-104. doi: 10.1016/j.ijcard.2019.05.044. Epub 2019 May 21.
5
Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity.替比夫定治疗慢性淋巴细胞性心肌炎与人类细小病毒 B19 转录活性。
ESC Heart Fail. 2018 Oct;5(5):818-829. doi: 10.1002/ehf2.12341. Epub 2018 Aug 11.
6
Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts.机械性心肌卸载：LV-IMPELLA、ECMELLA、BI-PELLA 和 PROPELLA 概念。
J Cardiovasc Transl Res. 2019 Apr;12(2):116-123. doi: 10.1007/s12265-018-9820-2. Epub 2018 Aug 6.
7
Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.β-干扰素治疗慢性病毒性心肌病（BICC）试验：干扰素-β治疗对慢性病毒性心肌病患者的影响。
Clin Res Cardiol. 2016 Sep;105(9):763-73. doi: 10.1007/s00392-016-0986-9. Epub 2016 Apr 25.
8
A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression.以转录活跃的心脏亲噬病毒和改变的心脏基因表达为特征的心肌病患者的一个明显亚组。
Basic Res Cardiol. 2013 Sep;108(5):372. doi: 10.1007/s00395-013-0372-y. Epub 2013 Aug 11.
9
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.心肌炎的病因、诊断、治疗和治疗的现有知识状况：欧洲心脏病学会心肌和心包疾病工作组的立场声明。
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d. doi: 10.1093/eurheartj/eht210. Epub 2013 Jul 3.
10
Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients.替比夫定治疗与慢性乙型肝炎患者乙型肝炎 e 抗原血清学转换和免疫调节作用有关。
J Viral Hepat. 2013 Apr;20 Suppl 1:9-17. doi: 10.1111/jvh.12059.